Ávila OJ, Sandoval CC, Cruz JA, Partida ML, Sandoval CBG, Estañol B

Language: Spanish
References: 38
Page: 493-499
PDF size: 596.82 Kb.

ABSTRACT

Introduction: The mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare disorder with simultaneous damage of the nuclear DNA (ncDNA) and mitochondrial DNA (mtDNA). It is clinically characterized by progressive ophthalmoplegia, peripheral neuropathy, leukoencephalopathy, gastrointestinal damage and premature death. Seven families with the MNGIE syndrome have been reported with thirty two patients affected either siblings or first cousins. Consanguinity has been reported once in the previous medical literature in two affected families. Patients and methods: We describe the clinical characteristics of a family with three sisters affected. One male brother did not have the disease. The siblings had consanguineous parents (first cousins). We made a search in Medline and PubMed up to September 2009 under the title of “Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) and ”oculogastrointestinal muscular dystrophy”[OGIMD]. Results: We describe the clinical findings, the features of the MRI of the brain, the nerve conduction velocities and muscle biopsies of two of the affected siblings. The eldest sister died prematurely at age twenty three. The disease began in late childhood with gastrointestinal disorders; progressive deterioration of their nutritional state, ophthalmoplegia, fatigue and proximal muscle weakness. The brain MRI showed severe leukoencephalopathy, the nerve conduction velocities were slow and the muscle biopsy demonstrated ragged red fibers. The clinical findings, course of the disease and laboratory findings were characteristic of MNGIE. Conclusions: There are seven reports of familial MNGIE and one isolated report of consanguinity in two different families. In the family described in this article one male sibling did not have the disease. This is suggestive of autosomic dominant or recessive form of inheritance and is against transmission of a mutated mitochondrial DNA by the mother. We did not find a family history of the disease in four previous generations. This report also shows that the mutation of the ncDNA can condition very important changes in the mtDNA, which seem to be the direct cause of the symptoms, and illustrates the complex relations between the two types of DNA.

REFERENCES

1. Finsterer J. Mitochondriopathies. Eur J Neurol 2004; 11: 163-86.

2. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994; 44: 721-7.

3. Nishino I, Spinazzola A, Hirano A. Thymidine phosphorylase gene mutations in MNGIE. A human mitochondrial disorder. Science 1999; 283: 689-92.

4. Nishino I, Spinazzola A, Hirano M. MNGIE: from nuclear DNA to mitochondrial DNA. Neuromuscul Disord 2001; 11: 7-10.

5. Filosto M, Tomelleri G, Tonin P, Scarpelli M, Vattemi G, Rizzuto N, et al. Neuropathology of mitochondrial diseases. Biosci Rep 2007; 27: 23-30.

6. Okamura K, Santa T, Nagae K, Omae T. Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria. J Neurol Sci 1976; 27: 79-91.

7. Papadimitriou A, Comi GP, Hadjigeorgiou GM, Bordoni A, et al. Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Neurology 1998; 51: 1086-92.

8. Mueller LA, Camilleri M, Emslie Smith M. Mitochondrial neurogastrointestinal encephalomyopaty: manometric and diagnostic features. Gastroenterol 1999; 116: 959-63.

9. Collier TG, Applegarth DA, Calne DB. Mitochondrial neurogastrointestinal encephalomyopathy with multiple deletions of mitochondrial DNA. Ann Neurol 1996; 40: 545.

10. Lowsky R, Davidson, Wolman S, Jeejeebhoy KN, Hegele RA. Familial visceral myopathy associated with a mitochondrial myopathy. Gut 1993; 34: 279-83.

11. Uncini A, Servidei S, Silvestri G, Manfredi G, et al. Ophtalmoplegia, demyelinating neuropathy, leukoencephlopathy, myopathy, and gastrointestinal dysfunction with multiple deletions of mitochondrial DNA: a mitochondrial multisystem disorder in search of a name. Muscle Nerve 1994; 17: 667-74.

12. Cave D, Compton C. Case records of the Massachusetts General Hospital. N Engl J Med 1990; 322: 829-41.

13. Simon LT, Horoupian DS, Dorffman LJ, Marks M, Herrick MK, Wasserstein P, et al. Polyneuropathy, ophtalmoplegia, leukoencephalopathy, and intestinal pseudo obstruction: POLIP syndrome. Ann Neurol 1990; 28: 349-60.

14. Threlkeld AB, Miller NR, Gormik KC, Griffin JW, Kunci RW, Johns DR, et al. Ophtalmic involvement in myoneurogastrointestinal encephalopathy syndrome. Am J Ophtalmol 1992; 114: 322-8.

15. Ionasescu V. Oculogastrointestinal muscular dystrophy. Am J Med Genet 1983; 15: 103-12.

16. Steiner I, Steinberg A, Argov Z, Faber J, et al. Familial progressive neuronal disease and chronic idiopathic intestinal pseudoobstruction. Neurology 1987; 37: 1046-50.

17. Bardosi A, Creutzfeld W, DiMauro S, Felgenhauer K, et al. Myoneurogastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome c oxidase a new mitochondrial multisystem disorder. Acta Neuropathol 1987; 74: 248-58.

18. Li V, Hostein J, Romero NB, Marsac C. Chronic intestinal pseudoobstruction with myopathy and ophtalmoplegia: a muscular biochemical study of a mitochondrial disorder. Dig Dis Sci 1992; 37: 456-63.

19. Cervera R, Bruix J, Bayes A, Blesa R. Chronic intestinal pseudoobstruction and ophtalmoplegia in a patient with mitochondrial myopaty. Gut 1988; 29: 544-7.

20. Faber J, Fich A, Steinberg A, Steiner I, et al. Familial intestinal pseudoobstruction dominated by a progressive neurologic disease at a young age. Gastroenterol 1987; 92: 786-90.

21. Carrozzo R, Hirano M, Fromenty B, Casali C, Santoreli FM, Bonillas E. Multiple mtDNA deletion features in autosomal dominant and recessive diseases suggest distinct pathogenesis. Neurology 1998; 50: 99-106.

22. Hamano H, Ohta T, Takekawa Y, Kouda K, Shinohara Y. Mitochondrial neurogastrointestinal encephalomyopathy presenting with protein losing gastroenteropathy and serum copper deficiency a case report. Rinsho Shinkeigaku 1997; 37: 917-22.

23. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 2000; 47: 792-800.

24. Debouverie M, Wagner M, Ducrocq X, Grignon Y, Mousson B, Weber M. MNGIE syndrome in 2 siblings. Rev Neurol 1997; 153: 547-53.

25. Monroy N, Macías-Kauffer LR, Mutchinick OM. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) in two Mexican brothers harboring a novel mutation in the ECGF1 gene. Eur J Med Genet 2008; 51: 245-50.

26. Schüpbach WM, Vadday KM, Schaller A, Brekenfeld C, Kappeler L, Benoist JF, et al. Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features. J Neurol 2007; 254: 146-53.

27. Gamez J, Ferreiro C, Accarino ML, Guarner L, Tadesse S, Martí RA, et al. Phenotypic variability in a Spanish family with MNGIE. Neurology 2002; 59: 455-7.

28. Haftel LT, Lev D, Barash V, Gutman A, Bujanover Y, Lerman-Sagie T. Familial mitochondrial intestinal pseudo-obstruction and neurogenic bladder. J Child Neurol 2000; 15: 386-9.

29. Papadimitriou A, Comi GP, Hadjigeorgiou GM, Bordoni A, Sciacco M, Napoli L, et al. Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Neurology 1998; 51: 1086-92.

30. Brown NS, Bicknell R. Thymidine phosphorylase, 2-deoxy D ribose and angiogenesis. Biochem J 1998; 334: 1-8.

31. Bestwick RK, Mathews CK. Unusual compartment of precursors for nuclear and mitocondrial DNA in mouse L cells. J Biol Chem 1982; 257: 9305-8.

32. Bogenhagen D, Clayton DA. Thymidylate nucleotide supply for mitochondrial DNA synthesis in mouse L cells. J Biol Chem 1976; 249: 2938-44.

33. Bestwick RK, Moffett GL, Mathews CK. Selective expansion of mitochondrial nucleoside triphosphate pools in antimetabolite treated HeLa cells. J Biol Chem 1982; 257: 9300-4.

34. Johanson M, Karlsson A. Cloning of the cDNA and chromosomal localization of the gene for human thymidine kinase 2. J Biol Chem 1997; 13: 8454-8.

35. Saada A, Shaag A, Mandel H, et al. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001; 29: 342-4.

36. Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001; 29: 337-41.

37. Kaukonen J, Juselius JK, Tiranti V, et al. Role of adenine nucleotide translocator in mtDNA maintenance. Science 2000; 289: 782-5.

38. Spelbrink JN, Li FY, Tiranti V, et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4 like protein localized in mitochondria. Nat Genet 2001; 28: 223-31.